Seval Akay

5PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersOral and maxillofacial surgeryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|Jan 28, 2026
Prevalence and Clinical Associations of Germline DDR Variants in Prostate Cancer: Real-World Evidence from a 122-Patient Turkish Cohort.

Seval Akay, Taha Resid Ozdemir, Ozge Ozer Kaya

|Jan 28, 2026
Clinicopathologic Features and Postoperative Outcomes of Parotidectomy: A 16-Year Retrospective Cohort Study from a Tertiary Referral Center.

Seval Akay, Ozlem Yagiz Agayarov, Volkan Semiz

|Apr 26, 2025
Comparison of Clinicopathological Characteristics for HER2-Null, HER2-Ultralow and HER2-Low Breast Cancer: A Single-Center Study.

Seval Akay, Mumin Emiroglu, Canan Kelten Talu

|Nov 26, 2024
Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study.

Sercan Ön, Barış Köksal, Zafer Arık

Pageof 1

Frequent Collaborators

2 joint publications

Olcun Umit Unal

1 joint publications

Sercan Ön

1 joint publications

Barış Köksal

1 joint publications

Burcu Caner